English
Ying-Hsia Chu
39 posts
Ying-Hsia Chu
@hsia_chu
Head and Neck/Molecular Pathologist in Taiwan, certified in Taiwan (AP) and the United States (AP/CP, MGP)
Taoyuan, Taiwan Katılım Mayıs 2020
179 Takip Edilen143 Takipçiler
Interested in the role of #MolDx in determining tumors of unknown primary in #ENTPath? rdcu.be/fjm0l Check out this nice review from @hsia_chu @jfhang in @HeadNeckPathol #HANP in the collection edited by @adamsfisch of @MGHPathology
English
Ying-Hsia Chu retweetledi
Head and Neck Pathology reviews squamous cell carcinomas of unknown primary (SCCUP), which make up about 5% of head and neck cancers. The study highlights challenges in treatment due to the absence of a clear tumor origin.
bit.ly/4t2YdL6
English
#hnpath FGFR1/2/3‐rearranged carcinoma of the head and neck: expanded histological spectrum crossing path with high‐risk HPV in the sinonasal tract - Chu - Histopathology - Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/hi…
English
FGFR rearranged carcinomas in the head and neck - newly published series from MSK
onlinelibrary.wiley.com/share/author/G…
English
It's the smile Dr. Israa Laklouk gives every tumor-infiltrating lymphocyte, because she knows more about them than they know about themselves. Her poster: Tumor-Infiltrating Lymphocytes and Tertiary Lymphoid Structures in Renal Cell Carcinoma Predict Clinical Outcome
#USCAP2023
English
@PathDocBoston @EndoPath @MayoClinicPath Thank you, Peter. Looking forward to rejoining the Thursday case conference after switching time zones 😊
English
Beautiful chart from @hsia_chu’s @EndoPath review article! Catch her this summer as she joins the faculty @MayoClinicPath in Rochester in #ENTPath, #EndoPath & #MolDx
Xiaoyin "Sara" Jiang, MD (She/Her)@Sara_Jiang
The great @PathDocBoston showing mutations and targets in thyroid cancer at the Head and Neck evening session #USCAP2023 @TheUSCAP @hsia_chu ncbi.nlm.nih.gov/pmc/articles/P…
New Orleans, LA 🇺🇸 English
@nicolecipriani @JamesDolezal @RaymonGrogan @AhusainPath @DrJuhlin @darcykerrMD @XKeutgen @vanianose @lab_pearson @PathDocBoston Thank you for the opportunity to participate！
English
It's finally out! Thanks to all the contributors for their amazing articles and @JLHornick for entrusting this @clinicsinpath issue to me! sciencedirect.com/journal/surgic…
University of Chicago Pathology@UChicagoPath
Latest March 2023 issue of @clinicsinpath on endocrine pathology edited by @nicolecipriani sciencedirect.com/journal/surgic… Contributions from chief resident, Pari Jafari, @AhusainPath, @nsetia5, former residents (Vincent Cracolici and Becca Wolsky), and past H&N fellow (Fouad Zakka)
English
English
@EndoPath presents former @MGHPathology #ENTPath #EndoPath alum @hsia_chu's in depth review on kinase fusion-related #thyroidcancer. This #thyroid cancer responds to targeted therapy & every #pathologist who sees thyroids needs to know about them! link.springer.com/content/pdf/10…
English
Ying-Hsia Chu retweetledi
AFF2 immunohistochemistry is a highly sensitive and specific ancillary marker for DEK::AFF2 carcinoma. Check out our new article @ModernPathology @LewisPath @JudyShi8 @JaylouVelez @hsia_chu @WeinrebIlan #HeadNeckPathol #HeadandNeckPath #ENTPath
👉nature.com/articles/s4137…
English
My first validation project from fellowship just got published on a novel assay that detects a broad range of actionable fusions in 3 hours from FFPE to report. Many thanks to mentors, colleagues and friends from MSK.
The Journal of Molecular Diagnostics@JMDiagn
#ArticleinPress: Clinical utility and performance of an ultra-rapid multiplex RNA-based assay for detection of ALK, ROS1, RET and NTRK1/2/3 rearrangements and MET exon 14 skipping alterations. @AMPath member authors from @MSKCancerCenter. Full text: jmdjournal.org/article/S1525-…
English
Ying-Hsia Chu retweetledi
Ukrainian soldiers with cats 🐱
Providence, RI 🇺🇸 English
@PathDocBoston Thank you, Peter :) It’s been great working with you! I’m working on the review which will be finished by mid-November 😄
English
One of my favorite papers written by stellar @MGHPathology #ENTPath #EndoPath fellow @hsia_chu (Ying-Hsia Chu) now on faculty in Taiwan before we hope to swipe right & get her back to the US! nature.com/articles/s4137… Truly helpful diagnostic add in #thyroid ca
MGH Pathology@MGHPathology
Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization ✏️ Vânia Nosé 1, William C Faquin 1 (@bfaquin), Peter M Sadow 3 (@PathDocBoston) 🗓️ 2020 Dec 🌐 pubmed.ncbi.nlm.nih.gov/32737449/ #MGHPathPublication
English
@MLisaZhang @MGHPathology @harvardmed @marthabpitman @Vik_deshpandeMD @cjvand @ALBoothMD @CArnold_GI @mzehraordulu @PathDocBoston @vanianose @v_y_jo @yaelheher Congratulations!
English
I am beyond excited to announce that I will be joining the faculty @MGHPathology @harvardmed next year and will be doing #CytoPath and #GIPath! My deepest thanks to all who supported me along the way, and I hope to continue learning from and connecting with everyone!
English
@PathDocBoston @MassEyeAndEar Haha! Maybe worth creating a new text abbreviation for writing frozen diagnosis 👍
English
#MolDx has come so far that we may depend on it for certain entities, & yet we get playfully chided by surgeons who (reasonably) want to know NOW. Love when I call in an easy intraop dx & hear "I suppose we're waiting for molecular?" ♥️ @MassEyeAndEar #ENT #ENTSurgery #ENTPath
English
@PathDocBoston Thank you! That brings great memory to me with lots of fun stories in the MGH head and neck group :)
English
@hsia_chu It’s still my pinned tweet! :)
Boston, MA 🇺🇸 English
I thought pathologists were cleverest, as I wrote to an #ENTOnc & #ENTsurgeon, having predicted the correct thyroid gene fusion in my note, now confirmed, with a mic drop 🎤. He retorted, in my case, it was a different mic🔬drop. He wins. #PathHumor @ScarlessThyroid
English
@PathDocBoston Awesome! I’m glad that our histology approach/algorithm works outside of the study cohort 😊
English
Ying-Hsia Chu retweetledi
Human Pathology@Human_Pathology
Fisch et. al. propose an algorithm that integrates histological elements (atypia, invasiveness) and specific molecular alterations to increase diagnostic accuracy in cases of Intraductal Carcinoma of the Salivary Gland with NCOA4-RET #HumPathol sciencedirect.com/science/articl…
Provincetown, MA 🇺🇸 English
Ying-Hsia Chu retweetledi
Intraductal carcinoma of the salivary gland with NCOA4-RET: expanding the morphologic spectrum and an algorithmic diagnostic approach - ScienceDirect sciencedirect.com/science/articl…
English